Northstar Neuroscience Announces Completion of Enrollment in Feasibility Study of Cortical Stimulation to Treat Stroke-Related Broca's Aphasia.
Linked as:
Extract
Northstar Neuroscience Announces Completion of Enrollment in Feasibility Study of Cortical Stimulation to Treat Stroke-Related Broca's Aphasia.
SEATTLE -- Northstar Neuroscience, Inc. (NASDAQ: NSTR), a developer of medical devices for the treatment of neurological diseases and disorders, today announced the completion of patient enrollment and randomization in its feasibility study of cortical ...
See the full content of this document
Sponsored links
